Mylène Jansen

180 Chapter 9 effectiveness of KJD treatment with the KneeReviver should take into account the difference in patient population. In any case, these results stress the importance of defining clear inclusion criteria, and ensuring these criteria are met when selecting patients for treatment with KJD. In conclusion, the newly developed user-friendly KneeReviver device enables successful KJD treatment and is broadly spoken non-inferior compared to the previously used Dynamic Monotubes. Based on the first-year data, long-term follow-up and analyses are warranted and necessary to further conclude whether the KneeReviver can postpone a TKA as the Dynamic Monotubes frame has shown thus far.